Get the latest on all new medications approved and marketed in 2019—including their indications for use, routes of administration, and associated precautions. This can’t-miss session will review each new therapeutic agent and its role in therapy. Where applicable, Dr. Hussar will compare new therapies to existing agents and help you determine whether newer is better. Patient education tips and practical monitoring considerations round out this valuable update.
At the completion of this knowledge-based activity, participants will be able to:
- List new therapeutic agents that were approved and first marketed by FDA in 2019.
- Describe the mechanisms of action and indications for new therapeutic agents first marketed in 2019.
- Summarize adverse effects and patient safety considerations for new therapeutic agents first marketed in 2019.
- Compare new therapeutic agents first marketed in 2019 with other available therapeutic options.
Activity type: Knowledge-based
Target Audience: Pharmacists and PharmacyTechnicians
Learning Level: 1
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 2.0 contact hour of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-098-H01-P/T
To obtain credit for completing Your Annual New Drugs Update participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education assessment. Please note that you will not be permitted to submit the assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.Initial release date: April 1, 2020
Expiration date: March 20, 2023 - No credit granted after this date
Your Annual New Drugs Update is an activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association. © 2020 American Pharmacists Association
Daniel Hussar and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA2020 Virtual Education package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-20-098-H01-P||0.2 CEUs||March 20, 2020 - March 20, 2023|
|ACPE# 0202-0000-20-098-H01-T||0.2 CEUs||March 20, 2020 - March 20, 2023|